Development Pre-Seed
Validose
Medication Adherence
Validose is creating a new paradigm in clinical drug adherence by integrating objective dosing technology, real-time data sharing, and personalized patient coaching to enhance clinical trial success, accelerate pharmaceutical decision-making, and improve patient outcomes.
Development Pre-Seed
Validose
Medication Adherence
Validose is creating a new paradigm in clinical drug adherence by integrating objective dosing technology, real-time data sharing, and personalized patient coaching to enhance clinical trial success, accelerate pharmaceutical decision-making, and improve patient outcomes.
Development Pre-Seed
Validose
Medication Adherence
Validose is creating a new paradigm in clinical drug adherence by integrating objective dosing technology, real-time data sharing, and personalized patient coaching to enhance clinical trial success, accelerate pharmaceutical decision-making, and improve patient outcomes.
The opportunity
Clinical leads in Biopharma need accurate dosing data; data about who is dosing, and patient compliance with the protocol, outside of the clinical setting.“Much of the FDA approval process is based on what patients say they did.” - Clinical Director, Pharma R&D
The solution
An intelligent dosing and data platform; we derive real time intelligence around drug adherence and efficacy for any drug medium, at any scale. Validose fills the key data gaps in real world evidence in patients’ lives: when, where, and how much of a given therapy is delivered.
The opportunity
Clinical leads in Biopharma need accurate dosing data; data about who is dosing, and patient compliance with the protocol, outside of the clinical setting.“Much of the FDA approval process is based on what patients say they did.” - Clinical Director, Pharma R&D
The solution
An intelligent dosing and data platform; we derive real time intelligence around drug adherence and efficacy for any drug medium, at any scale. Validose fills the key data gaps in real world evidence in patients’ lives: when, where, and how much of a given therapy is delivered.
The opportunity
Clinical leads in Biopharma need accurate dosing data; data about who is dosing, and patient compliance with the protocol, outside of the clinical setting.“Much of the FDA approval process is based on what patients say they did.” - Clinical Director, Pharma R&D
The solution
An intelligent dosing and data platform; we derive real time intelligence around drug adherence and efficacy for any drug medium, at any scale. Validose fills the key data gaps in real world evidence in patients’ lives: when, where, and how much of a given therapy is delivered.
+2.3X
Larger patient panels due to expected non-adherence
30%
Clinical trials fail
+1.7X
survival rate without any biochemical treatment
+2.3X
Larger patient panels due to expected non-adherence
30%
Clinical trials fail
+1.7X
survival rate without any biochemical treatment
+2.3X
Larger patient panels due to expected non-adherence
30%
Clinical trials fail
+1.7X
survival rate without any biochemical treatment
ARTICLES
Press
Bringing Hospital-Level Care to Rural America
Feb 25, 2025
Brooklyn-based 10XBeta is developing a modular mobile healthcare platform...
Press
10XBeta Selected by ARPA-H's PARADIGM Program to Transform Rural Healthcare
Feb 19, 2025
10XBeta will lead the development of an integrated, scalable mobile platform designed to bring cutting-edge healthcare services to underserved rural communities
Press
Validose Secures $2M in Pre-Seed Funding to Solve Clinical Trial Medication Adherence
Feb 18, 2025
The platform is the first to combat non-adherence in clinical trials, a cause of 30% of failures...
Press
Bringing Hospital-Level Care to Rural America
Feb 25, 2025
Brooklyn-based 10XBeta is developing a modular mobile healthcare platform...
Press
10XBeta Selected by ARPA-H's PARADIGM Program to Transform Rural Healthcare
Feb 19, 2025
10XBeta will lead the development of an integrated, scalable mobile platform designed to bring cutting-edge healthcare services to underserved rural communities
Press
Bringing Hospital-Level Care to Rural America
Feb 25, 2025
Brooklyn-based 10XBeta is developing a modular mobile healthcare platform...
Press
10XBeta Selected by ARPA-H's PARADIGM Program to Transform Rural Healthcare
Feb 19, 2025
10XBeta will lead the development of an integrated, scalable mobile platform designed to bring cutting-edge healthcare services to underserved rural communities
Press
Validose Secures $2M in Pre-Seed Funding to Solve Clinical Trial Medication Adherence
Feb 18, 2025
The platform is the first to combat non-adherence in clinical trials, a cause of 30% of failures...
